105 related articles for article (PubMed ID: 38779867)
1. The Tumor Immune Microenvironment in Breast Cancer Progression.
Otterlei Fjørtoft M; Huse K; Rye IH
Acta Oncol; 2024 May; 63():359-367. PubMed ID: 38779867
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
3. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
4. The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
Goff SL; Danforth DN
Clin Breast Cancer; 2021 Feb; 21(1):e63-e73. PubMed ID: 32893093
[TBL] [Abstract][Full Text] [Related]
5. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
Nascimento C; Ferreira F
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
[TBL] [Abstract][Full Text] [Related]
7. The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.
Badr NM; Berditchevski F; Shaaban AM
Pathobiology; 2020; 87(2):61-74. PubMed ID: 31715606
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.
Bouzidi L; Triki H; Charfi S; Kridis WB; Derbel M; Ayadi L; Sellami-Boudawara T; Cherif B
Clin Breast Cancer; 2021 Dec; 21(6):e738-e747. PubMed ID: 33727019
[TBL] [Abstract][Full Text] [Related]
9. The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Waks AG; Stover DG; Guerriero JL; Dillon D; Barry WT; Gjini E; Hartl C; Lo W; Savoie J; Brock J; Wesolowski R; Li Z; Damicis A; Philips AV; Wu Y; Yang F; Sullivan A; Danaher P; Brauer HA; Osmani W; Lipschitz M; Hoadley KA; Goldberg M; Perou CM; Rodig S; Winer EP; Krop IE; Mittendorf EA; Tolaney SM
Clin Cancer Res; 2019 Aug; 25(15):4644-4655. PubMed ID: 31061067
[TBL] [Abstract][Full Text] [Related]
10. B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Steenbruggen TG; Wolf DM; Campbell MJ; Sanders J; Cornelissen S; Thijssen B; Salgado RA; Yau C; O-Grady N; Basu A; Bhaskaran R; Mittempergher L; Hirst GL; Coppe JP; Kok M; Sonke GS; van 't Veer LJ; Horlings HM
Breast Cancer Res; 2023 Oct; 25(1):117. PubMed ID: 37794508
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer.
Cherif B; Triki H; Charfi S; Bouzidi L; Kridis WB; Khanfir A; Chaabane K; Sellami-Boudawara T; Rebai A
Sci Rep; 2021 Apr; 11(1):7550. PubMed ID: 33824367
[TBL] [Abstract][Full Text] [Related]
12. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
[TBL] [Abstract][Full Text] [Related]
13. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
Burugu S; Asleh-Aburaya K; Nielsen TO
Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
[TBL] [Abstract][Full Text] [Related]
14. Prognosis significance of indoleamine 2, 3-dioxygenase, programmed death ligand-1 and tumor-infiltrating immune cells in microenvironment of breast cancer.
Wei L; Wu N; Wei F; Li F; Zhang Y; Liu J; Ren X
Int Immunopharmacol; 2020 Jul; 84():106506. PubMed ID: 32330866
[TBL] [Abstract][Full Text] [Related]
15. New insights into the role of the immune microenvironment in breast carcinoma.
de la Cruz-Merino L; Barco-Sánchez A; Henao Carrasco F; Nogales Fernández E; Vallejo Benítez A; Brugal Molina J; Martínez Peinado A; Grueso López A; Ruiz Borrego M; Codes Manuel de Villena M; Sánchez-Margalet V; Nieto-García A; Alba Conejo E; Casares Lagar N; Ibáñez Martínez J
Clin Dev Immunol; 2013; 2013():785317. PubMed ID: 23861693
[TBL] [Abstract][Full Text] [Related]
16. Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review).
Chen H; Sun Y; Yang Z; Yin S; Li Y; Tang M; Zhu J; Zhang F
Oncol Rep; 2021 Mar; 45(3):846-856. PubMed ID: 33650671
[TBL] [Abstract][Full Text] [Related]
17. Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients.
Smolkova B; Cierna Z; Kalavska K; Miklikova S; Plava J; Minarik G; Sedlackova T; Cholujova D; Gronesova P; Cihova M; Majerova K; Karaba M; Benca J; Pindak D; Mardiak J; Mego M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322711
[TBL] [Abstract][Full Text] [Related]
18. Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
Ding S; Qiao N; Zhu Q; Tong Y; Wang S; Chen X; Tian Q; Xiao Y; Shen K
Cancer Commun (Lond); 2023 Jun; 43(6):661-684. PubMed ID: 37158690
[TBL] [Abstract][Full Text] [Related]
19. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.
Huang Y; Ma C; Zhang Q; Ye J; Wang F; Zhang Y; Hunborg P; Varvares MA; Hoft DF; Hsueh EC; Peng G
Oncotarget; 2015 Jul; 6(19):17462-78. PubMed ID: 25968569
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study.
Zeppellini A; Galimberti S; Leone BE; Pacifico C; Riva F; Cicchiello F; Capici S; Maggioni C; Sala L; Cazzaniga ME
BMC Cancer; 2021 Mar; 21(1):260. PubMed ID: 33691674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]